Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting

Danville, CA – (May 15, 2017) – Palo Alto Health Sciences, Inc. (PAHS), developer of Freespira®, the only FDA-cleared digital therapeutic for panic attacks and symptoms of panic disorder, today announced that clinical results from the most recent trial will be presented at the Continue reading “Clinical Results of Drug-Free Freespira® Treatment for Panic to be Presented at Clinical TMS Society Annual Meeting”